About Neubond

We believe that everyone deserves the opportunity to recover

Our advanced, patient-centred technology is designed to make rehabilitation more effective and accessible. By combining technical expertise with a dedication to real-world translational impact, Neubond offers a solution that empowers patients to regain control of their lives.

Built on passion

Neubond, co-founded by Patrick and Jumpei, was born from a shared passion for using technology to impact healthcare in revolutionary ways. Starting with advancements in prosthetics, Patrick and Jumpei saw the transformative power of tech in helping patients regain mobility. They recognised that technology could extend far beyond prosthetics and be applied to stroke and neuro-rehabilitation, ultimately addressing a pressing gap in patient recovery solutions.

A gap in rehabilitation

3hrs

Minimum recommended daily therapy1

>60%

Unmet target therapy2

Stroke is the leading cause of disability, affecting over 12M people annually. Survivors often face long-term paralysis, losing independence and quality of life. While intensive physical therapy is key to recovery, access to therapists is limited, and many patients struggle with motivation.

Our vision is to embed rehabilitation into daily life - making therapy continuous, accessible, and engaging - so recovery does not stop when therapy sessions do.

Pioneers in new technology

We are supported and recognised by the following organisations:

Supporter: LIHE
Supporter: ICURE
Supporter: NIHR
Supporter: V
Supporter: UKRI
Supporter: Imperial Enterprise Lab
Supporter: N.CODE

Collaborators

Thank you to the following stroke support groups that have provided valuable lived experience insights:

Our Team

Discover the driving force behind Neubond:

Dr. Patrick Sagastegui

Co-founder & Director

BEng., MRes, PhD. Electrical engineering, Bioengineering

Over six years in neurorehabilitation. Over nine years in electronics design. PhD in neuromodulation with a wearable neural interface.

View my LinkedIn
Jumpei Kashiwakura

Co-founder & Director

BEng., MEng., MSc, Mechanical engineering, Bioengineering.

Five years at Toyota Motor Corp as a system engineer based on Kaizen method. Over six years in neurorehabilitation.

View my LinkedIn
Risha Degamia

Translational Research Scientist

MSc, BSc (Hons) Neuroscience.

Over two years of experience in rehabilitation technologies, scientific communication and medtech marketing.

View my LinkedIn
Nabeel Azuhar

Software Engineer

MEng Biomedical Engineering, Imperial College London.

Proven experience delivering full-stack and systems integration solutions in healthcare-focused engineering roles.

View my LinkedIn
Vacant Position

Research Physiotherapist / Occupational Therapist

Full information on this position is posted on LinkedIn. Learn more about this position via the link below.

See description on LinkedIn
Vacant Position

Production & Manufacturing Engineer (Medical Devices)

Full information on this position is posted on LinkedIn. Learn more about this position via the link below.

See description on LinkedIn

Board

Prof. Dr. Dario Farina

Scientific Advisor, Co-Founder

World leading Neurohabilitation researcher > 400 publications.

Dr. Paul Bentley

Clinical Advisor

Clinical director in Rehab Technologies.

Milly Barker

Operational Advisor

Founder at Pay as You Go COO.

Neil Roberts

Commercial Advisor

Managing director at SETHA.

Interested in participating?

Join our waiting list today to get early access for pilot and beta testing.

Join Waiting List
References:

1. "Stroke rehabilitation in adults NICE guideline", 2023. [Online]. Available: www.nice.org.uk/guidance/ng236. 2. M. Gittins et al., "Factors influencing the amount of therapy received during inpatient stroke care: an analysis of data from the UK Sentinel Stroke National Audit Programme,"" Clin Rehabil, vol. 34, no. 7, pp. 981-991, Jul. 2020, doi: 10.1177/0269215520927454.

© Copyright Neubond Ltd 2026